Fate-AI, in this scenario, reaches consistently high accuracy in CRC with an AUC of 0.82 at TF 10−4, lung cancer with an of AUC 0.82 at TF 10−3, and melanoma with an AUC 0.9 at TF 10−3 (Figure 3B). This evidence concerns the gene TF and lung carcinoma.